← Leaderboards
Douglas Faigel
Mayo Clinic Arizona
$980,049
Attributed
$1,960,098
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $678.4K · FY2016–18$1M$750K$500K$250K$0
'16
'17
'18
Funding mix
By agency
NIH$1,960,098 · 1
By mechanism
R01$1,960,098 · 1
Top collaborators
- Eduard A. Sergienko3 shared
Most similar at Mayo Clinic Arizona
Same institution · by research overlap
- Eduard A. Sergienko$20,721,252
- Laurence J Miller$18,092,149
Others in their field
Top investigators on “Cytotoxicity”
- David Heimbrook · Leidos Biomedical Research, Inc.$60,494,681
- Philip J Disaia · University Of California Irvine$58,213,103
- Kent J. Weinhold · Duke University$45,381,151
- Brenda J. Weigel · University Of Minnesota$36,792,183
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$34,242,475
- Douglas F Nixon · J. David Gladstone Institutes$30,748,895
Research focus
CytotoxicityDatabasesAutophagocytosisAnalogApoptosisBasement MembraneBiochemicalBiologicalBackBreast Cancer SurvivalBaseCancer Cell GrowthCancer Cell LineCancer PatientCarcinogenesisCell CycleCell GrowthCell PhysiologyCell ProliferationBreast Cancer Cell LineCheminformaticsChemotherapy-Oncologic ProcedureCancer CellData Sources
Grant awards (3)
High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1$648,006
R01 · FY2018 · CA · contact PI
High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1$678,423
R01 · FY2017 · CA · contact PI
High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1$633,669
R01 · FY2016 · CA · contact PI